Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SinuNase in refractory postsurgical chronic sinusitis
NCT00425620Phase 3Completed
- Sponsor
- Accentia Biopharmaceuticals
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amphotericin b in sinusitis, sponsored by Accentia Biopharmaceuticals. Started Dec 2006; status: completed.
02
Drugs
amphotericin b
03
Conditions
sinusitis
Beyond the preview
Go deeper on NCT00425620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00425620.